Navigation Links
Czech Authorities Kill 70,000 Birds at H5N1 Farms

Around 70,000 birds have been killed at two Czech poultry farms where the H5N1 strain of bird flu, which is potentially fatal to humans, was confirmed this week, veterinary authorities said Friday .

Czech authorities have also decided to kill a further 70,000 birds, mostly chickens and turkeys, on three nearby farms even though bird flu has not been detected there, veterinary service spokesman Josef Duben.

"Around 70,000 have been killed," at two farms near the village of Norin in the centre of the country where the virus was confirmed on Wednesday, he told AFP.

The two farms are within an exclusion zone thrown up after the first cases of H5N1 were detected in domestic Czech poultry last month.

"We are doing this preventively. It is a decision we have taken ourselves in discussion with European authorities," Duben said, adding that compensation for the latest cull is likely to be around 30 million koruna (1.05 million euros, 1.46 million dollars).

He said decontamination of the poultry farms will continue over the weekend.

Since the initial Czech outbreak in June, other cases of the H5N1 strain of bird flu have been declared in France and Germany.


'"/>




Page: 1

Related medicine news :

1. Czech Republic struck by fifth bird flu incident
2. 6,000 Turkeys Slaughtered at Czech Bird Flu Farm
3. H5N1 Bird Flu Confirmed at Czech Turkey Farm
4. British Authorities Seize Spurious Drugs
5. Health Authorities Claim Some Relief likely from Post floods diseases in Mumbai
6. Strange Theft Of HIV Infected Blood Leaves Authorities Puzzled
7. Health Authorities Take Step to Control MRSA Infection
8. Meth Addiction On The Rise, US Health Authorities Concerned
9. Couple Try To Hoodwink Authorities By Remarrying
10. Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
11. Calgary Health Authorities Apologize to Woman over Miscarriage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Guruji Mahendra ... 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... happiness. Mahendra Trivedi is known by over 250,000 people from over 40 different ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women’s Excellence now ... the most minimally invasive approaches. , Women who have had multiple vaginal births ... factors include surgery to the pelvic floor, connective tissue disorders, and obesity. Women ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX ... warm color grades to their footage. A LUT is a Lookup Table that contains ... the corresponding color indicated by the table. By manipulating each pixel, LUT's can change ...
(Date:2/5/2016)... ... , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon ... 2003. This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped ... Heat. , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- HemaFlo Therapeutics, Inc. announced today that the United States Patent ... covering the use of NephroFlow to treat acute kidney injury ... said, "We are pleased to secure our rights to such ... PhD, HemaFlo,s founder, said, "We are pleased to secure our ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ...
(Date:2/8/2016)... , Feb. 8, 2016  Dynatronics Corporation ... of advanced-technology medical devices and rehabilitation equipment for ... congratulates the Denver Broncos, football team for winning ... Cullimore Jr. , Chairman and Chief Executive Officer.  ... and we look forward to enhancing their athletic ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
Breaking Medicine Technology: